These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1955133)

  • 1. Differential inhibition of individual human liver cytochromes P-450 by cimetidine.
    Knodell RG; Browne DG; Gwozdz GP; Brian WR; Guengerich FP
    Gastroenterology; 1991 Dec; 101(6):1680-91. PubMed ID: 1955133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for induction of hepatic microsomal cytochrome P-450 by cimetidine: binding and kinetic studies.
    Ioannoni B; Mason SR; Reilly PE; Winzor DJ
    Arch Biochem Biophys; 1986 Jun; 247(2):372-83. PubMed ID: 3087288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of the histamine H2-receptor antagonist etintidine with rat liver cytochrome P-450: a comparison with cimetidine.
    Schulz M; Schmoldt A
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):453-8. PubMed ID: 2893298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cimetidine interaction with liver microsomes in vitro and in vivo. Involvement of an activated complex with cytochrome P-450.
    Jensen JC; Gugler R
    Biochem Pharmacol; 1985 Jun; 34(12):2141-6. PubMed ID: 3924056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of rat hepatic microsomal cytochrome P-450. II. Effect of the in vitro administration of cimetidine.
    Chang T; Levine M; Bellward GD
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1450-5. PubMed ID: 1545404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA; Tjia JF; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats.
    Levine M; Law EY; Bandiera SM; Chang TK; Bellward GD
    J Pharmacol Exp Ther; 1998 Feb; 284(2):493-9. PubMed ID: 9454789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cimetidine and ranitidine: their interaction with human and pig liver microsomes and with purified cytochrome P-450.
    Rendić S; Ruf HH; Weber P; Kajfez F
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):195-200. PubMed ID: 6097454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole.
    Furuta S; Kamada E; Suzuki T; Sugimoto T; Kawabata Y; Shinozaki Y; Sano H
    Xenobiotica; 2001 Jan; 31(1):1-10. PubMed ID: 11334262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cimetidine on dextromethorphan O-demethylase activity of human liver microsomes and recombinant CYP2D6.
    Madeira M; Levine M; Chang TK; Mirfazaelian A; Bellward GD
    Drug Metab Dispos; 2004 Apr; 32(4):460-7. PubMed ID: 16680870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of rat hepatic microsomal cytochrome P-450. I. Effect of the in vivo administration of cimetidine.
    Chang T; Levine M; Bandiera SM; Bellward GD
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1441-9. PubMed ID: 1545403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cimetidine on microsomal drug metabolism in man.
    Puurunen J; Sotaniemi E; Pelkonen O
    Eur J Clin Pharmacol; 1980 Aug; 18(2):185-7. PubMed ID: 7428801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidations.
    Miners JO; Smith KJ; Robson RA; McManus ME; Veronese ME; Birkett DJ
    Biochem Pharmacol; 1988 Mar; 37(6):1137-44. PubMed ID: 3355588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes.
    Bourrié M; Meunier V; Berger Y; Fabre G
    Drug Metab Dispos; 1999 Feb; 27(2):288-96. PubMed ID: 9929518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (+)-bufuralol 1'-hydroxylation activity in human and rhesus monkey intestine and liver.
    Prueksaritanont T; Dwyer LM; Cribb AE
    Biochem Pharmacol; 1995 Oct; 50(9):1521-5. PubMed ID: 7503805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human CYP3A catalyzed 1'-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine.
    Wrighton SA; Ring BJ
    Pharm Res; 1994 Jun; 11(6):921-4. PubMed ID: 7937537
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes.
    Kerlan V; Dreano Y; Bercovici JP; Beaune PH; Floch HH; Berthou F
    Biochem Pharmacol; 1992 Nov; 44(9):1745-56. PubMed ID: 1449532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.